Viemed Healthcare Files 8-K: Director Changes & Officer Compensation

Ticker: VMD · Form: 8-K · Filed: Jun 6, 2024 · CIK: 1729149

Viemed Healthcare, Inc. 8-K Filing Summary
FieldDetail
CompanyViemed Healthcare, Inc. (VMD)
Form Type8-K
Filed DateJun 6, 2024
Risk Levelmedium
Pages3
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: management-change, compensation, governance

TL;DR

Viemed Healthcare's 8-K shows director changes and officer comp updates. Board shakeup incoming?

AI Summary

On June 6, 2024, Viemed Healthcare, Inc. filed an 8-K report detailing several key events. These include the departure of a director, the election of a new director, and adjustments to compensatory arrangements for certain officers. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.

Why It Matters

This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.

Risk Assessment

Risk Level: medium — Changes in directorship and officer compensation can signal internal shifts that may affect future performance or strategy.

Key Players & Entities

  • Viemed Healthcare, Inc. (company) — Registrant
  • June 6, 2024 (date) — Date of earliest event reported

FAQ

Who is the departing director and who is the newly elected director?

The filing mentions the departure of a director and the election of a new director, but specific names are not provided in the provided text.

What specific changes were made to the compensatory arrangements for certain officers?

The filing indicates adjustments to compensatory arrangements for certain officers, but the details of these changes are not specified in the provided text.

What matters were submitted to a vote of security holders?

The filing states that matters were submitted to a vote of security holders, but the nature of these matters is not detailed in the provided text.

What are the key financial statements and exhibits included in this filing?

The filing notes the inclusion of financial statements and exhibits, but their specific content is not described in the provided text.

What is Viemed Healthcare's principal executive office address?

Viemed Healthcare's principal executive offices are located at 625 E. Kaliste Saloom Rd., Lafayette, Louisiana 70508.

Filing Stats: 827 words · 3 min read · ~3 pages · Grade level 8.6 · Accepted 2024-06-06 17:24:39

Filing Documents

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. At the Meeting, the Company's shareholders voted on: (1) eight nominated directors to be elected to the Board to serve until the close of the next annual meeting of shareholders or until their successors are elected; (2) the appointment of Ernst & Young LLP as auditors of the Company for the fiscal year ending December 31, 2024 and authorizing the Board to fix their remuneration and (3) an ordinary resolution to ratify, confirm, and approve the Plan. The tables below set forth the number of votes cast for, against, or withheld, and the number of broker non-votes for each matter voted on by the Company's shareholders. 1. Election of Directors Each of the eight nominees listed below were elected as directors of the Company to hold office until the next annual meeting of shareholders or until their successors are elected. Name Votes For % For Votes Withheld % Withheld Casey Hoyt 24,576,928 97.47% 638,985 2.53% W. Todd Zehnder 24,488,105 97.11% 727,808 2.89% William Frazier 24,167,031 95.84% 1,048,882 4.16% Randy Dobbs 24,853,882 98.56% 362,031 1.44% Nitin Kaushal 21,286,564 84.42% 3,929,349 15.58% Timothy Smokoff 21,750,402 86.26% 3,465,511 13.74% Bruce Greenstein 20,524,212 81.39% 4,691,701 18.61% Sabrina Heltz 23,970,293 95.06% 1,245,620 4.94% The number of broker non-votes for all directors was 4,302,487. 2. Appointment of Auditors The shareholders approved the appointment of Ernst & Young LLP as auditors of the Company for the fiscal year ending December 31, 2024 and the authorization of the Board to fix their remuneration. Votes For % For Votes Withheld % Withheld Broker Non-Votes 29,420,869 99.67% 97,531 0.33% — 3. Security Based Compensation Plan The shareholders passed an ordinary resolution to ratify, confirm, and approve the Plan. Votes For % For Votes Against % Against Broker Non-Votes 17,451,585 69.21% 7,764,328 30.79% 4,302,487

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1 Viemed Healthcare, Inc. 202 4 Long Term Incentive Plan. 104 Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 6, 2024 VIEMED HEALTHCARE, INC. By: /s/ Trae Fitzgerald Trae Fitzgerald Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.